期刊名称：CANCER & METABOLISM
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims and scope
Cancer & Metabolism welcomes studies on all aspects of the relationship between cancer and metabolism, including:
- Molecular biology and genetics of cancer metabolism
Whole-body metabolism, including diabetes and obesity, in relation to cancer
- Metabolomics in relation to cancer;
- Metabolism-based imaging
- Preclinical and clinical studies of metabolism-related cancer therapies.
Open access
All articles published by Cancer & Metabolism are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Cancer & Metabolism you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.
Article-processing charges
Open access publishing is not without costs. Cancer & Metabolism therefore levies an article-processing charge of £1790.00/$2490.00/€2040.00 for each article accepted for publication, plus VAT or local taxes where applicable.
If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
BMC provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
Indexing services
All articles published in Cancer & Metabolism are included in:
- PubMed
- PubMed Central
- Emerging Science Citations Index (ESCI)
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
We are working closely with relevant indexing services including Web of Science (Clarivate Analytics) to ensure that articles published in Cancer & Metabolism will be available in their databases when appropriate.
Instructions to Authors
Our 3-step submission process
-
Before you submit
Now you’ve identified a journal to submit to, there are a few things you should be familiar with before you submit.
-
Ready to submit
To give your manuscript the best chance of publication, follow these policies and formatting guidelines.
-
Submit and promote
After acceptance, we provide support so your article gains maximum impact in the scientific community and beyond.
Please note that manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.
Submit manuscript
Criteria
Rapid communications are suitable for the presentation of research that extends previously published research, including the reporting of additional controls and confirmatory results in other settings, as well as negative results, small-scale clinical studies, clinical audits and case series. Authors must clearly acknowledge any work upon which they are building, both published and unpublished.
Editorial Board
Editors-in-Chief
Michael Pollak, McGill University and Lady Davis Research Institute, Canada
Matthew Vander Heiden, Massachusetts Institute of Technology, USA
Editor Emeritus
Chi Van Dang, Abramson Cancer Centre, University of Pennsylvania, USA
Senior Editors
Kevin Brindle, University of Cambridge, UK
Navdeep Chandel, Northwestern University, USA
Eyal Gottlieb, Beatson Institute for Cancer Research, UK
Editorial Board
Abass Alavi, University of Pennsylvania School of Medicine, USA
Lewis Cantley, Weill Cornell Medical College, USA
Peter Carmeliet, Vesalius Research Center, Belgium
Teresa Fan, Markey Cancer Center, USA
Robert Gatenby, H. Lee Moffitt Cancer Center and Research Institute, USA
Kun-Liang Guan, University of California, San Diego, USA
Rudolf Kaaks, German Cancer Research Center, Germany
Andrew Lane, Markey Cancer Center, USA
Gordon Mills, University of Texas M. D. Anderson Cancer Center, USA
Jacques Pouyssegur, Institute of Research on Cancer and Aging, France
Joshua Rabinowitz, Princeton University, USA
Peter Ratcliffe, Nuffield Department of Clinical Medicine, UK
Jeffrey Rathmell, Duke University, USA
Jared Rutter, University of Utah School of Medicine, USA
David Sabatini, Whitehead Institute for Biomedical Research, USA
Paolo Sassone-Corsi, University of California, Irvine, USA
Gregg Semenza, Johns Hopkins University School of Medicine, USA
Celeste Simon, University of Pennsylvania School of Medicine, USA
Alexei Vazquez, The Cancer Institute of New Jersey, USA
Bert Vogelstein, Johns Hopkins University School of Medicine, USA
Karen Vousden, Beatson Institute for Cancer Research, UK
Kathryn Wellen, University of Pennsylvania, USA
Eileen White, The Cancer Institute of New Jersey, USA
Yue Xiong, University of North Carolina, Chapel Hill, USA
|
